4//SEC Filing
VALE WYLIE W 4
Accession 0001126488-04-000017
CIK 0000914475other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 3:17 PM ET
Size
20.1 KB
Accession
0001126488-04-000017
Insider Transaction Report
Form 4
VALE WYLIE W
Director
Transactions
- Sale
Common Stock
2004-09-01$50.07/sh−1,400$70,098→ 288,672 total - Sale
Common Stock
2004-09-01$50.11/sh−900$45,099→ 290,472 total - Sale
Common Stock
2004-09-01$50.10/sh−200$10,020→ 290,272 total - Sale
Common Stock
2004-09-01$50.03/sh−1,500$75,045→ 286,672 total - Sale
Common Stock
2004-09-01$50.02/sh−100$5,002→ 286,372 total - Sale
Common Stock
2004-09-01$50.01/sh−2,000$100,020→ 284,372 total - Sale
Common Stock
2004-09-01$50.00/sh−3,000$150,000→ 281,372 total - Sale
Common Stock
2004-09-01$50.05/sh−500$25,025→ 288,172 total
Footnotes (2)
- [F1]The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person and delivered to the broker on February 11, 2004.
- [F2]205,630 shares are held by the Reporting Person; 75,742 shares held indirectly by WBV Limited Liability Company.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001126488
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 3:17 PM ET
- Size
- 20.1 KB